KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Globus Medical (GMED) Non Operating Income (2016 - 2025)

Globus Medical (GMED) has disclosed Non Operating Income for 15 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 366.95% year-over-year to $5.0 million, compared with a TTM value of $125.3 million through Dec 2025, up 5580.36%, and an annual FY2025 reading of $125.3 million, up 5580.36% over the prior year.
  • Non Operating Income was $5.0 million for Q4 2025 at Globus Medical, up from $1.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $112.1 million in Q2 2025 and bottomed at -$14.9 million in Q3 2023.
  • Average Non Operating Income over 5 years is $8.5 million, with a median of $2.1 million recorded in 2022.
  • The sharpest move saw Non Operating Income crashed 946.85% in 2023, then soared 11140.12% in 2025.
  • Year by year, Non Operating Income stood at $1.6 million in 2021, then crashed by 414.8% to -$5.1 million in 2022, then soared by 723.08% to $31.9 million in 2023, then crashed by 96.66% to $1.1 million in 2024, then skyrocketed by 366.95% to $5.0 million in 2025.
  • Business Quant data shows Non Operating Income for GMED at $5.0 million in Q4 2025, $1.5 million in Q3 2025, and $112.1 million in Q2 2025.